26-06-2020
The executive director of the Medicines Patent Pool (MPP) says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
MPP, LSPN Connect, Medicines Patent Pool, voluntary licensing, COVID-19, pandemic, Charles Gore, Big Pharma, drug companies, HIV, hepatitis C, WHO, UN
LSPN Connect: micro-managing with Pendulum Therapeutics
06-08-2020
LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity
31-07-2020
US to pay Pfizer nearly $2bn for COVID-19 vaccine supply
23-07-2020
LSPN Connect: When IP and COVID-19 meet
10-07-2020
WHO and Costa Rica to launch COVID-19 technology patent pool
19-05-2020
Costa Rica asks WHO to create voluntary COVID-19 IP pool
26-03-2020
